📗 Cite This Artifact
DNA Damage Repair Therapy - Biomarker Guided
Overview
DNA Damage Repair Therapy is a biomarker-driven treatment strategy that targets impaired DNA repair mechanisms in neurodegenerative diseases. Elevated DNA damage markers guide therapy selection and monitoring.
[Neurons](/entities/neurons) are particularly vulnerable to DNA damage due to high metabolic activity and limited regenerative capacity. Accumulation of DNA lesions contributes to neuronal dysfunction and cell death in AD, PD, and other neurodegenerative conditions.
Mechanism of Action
Measurable Biomarker Readouts
| Biomarker | Target | Measurement Method | Expected Change |
|-----------|--------|-------------------|-----------------|
| 8-OHdG (urine) | Decrease | LC-MS/MS | 40-60% reduction |
| 8-OHdG (CSF) | Decrease | ELISA | 30-50% reduction |
| gamma-H2AX | Decrease | Flow cytometry | 50-70% reduction |
| PAR levels | Normalize | ELISA | Return to baseline |
| Telomere length | Stabilize | qPCR | Prevent shortening |
DNA Damage Biomarkers
8-Hydroxy-2'-deoxyguanosine (8-OHdG)
- Marker of: Oxidative DNA damage
- Elevated in: AD, PD, ALS, Huntington's
- Correlation: Disease severity and progression
Gamma-H2AX
- Marker of: DNA double-strand breaks
- Elevated in: Ataxia telangiectasia, AD
- Therapeutic target: ATM pathway activation
Overview
DNA Damage Repair Therapy is a biomarker-driven treatment strategy that targets impaired DNA repair mechanisms in neurodegenerative diseases. Elevated DNA damage markers guide therapy selection and monitoring.
[Neurons](/entities/neurons) are particularly vulnerable to DNA damage due to high metabolic activity and limited regenerative capacity. Accumulation of DNA lesions contributes to neuronal dysfunction and cell death in AD, PD, and other neurodegenerative conditions.
Mechanism of Action
Measurable Biomarker Readouts
| Biomarker | Target | Measurement Method | Expected Change |
|-----------|--------|-------------------|-----------------|
| 8-OHdG (urine) | Decrease | LC-MS/MS | 40-60% reduction |
| 8-OHdG (CSF) | Decrease | ELISA | 30-50% reduction |
| gamma-H2AX | Decrease | Flow cytometry | 50-70% reduction |
| PAR levels | Normalize | ELISA | Return to baseline |
| Telomere length | Stabilize | qPCR | Prevent shortening |
DNA Damage Biomarkers
8-Hydroxy-2'-deoxyguanosine (8-OHdG)
- Marker of: Oxidative DNA damage
- Elevated in: AD, PD, ALS, Huntington's
- Correlation: Disease severity and progression
Gamma-H2AX
- Marker of: DNA double-strand breaks
- Elevated in: Ataxia telangiectasia, AD
- Therapeutic target: ATM pathway activation
Poly(ADP-ribose) (PAR)
- Marker of: PARP activation (DNA repair attempt)
- Elevated in: Neurodegeneration
- Therapeutic target: PARP inhibition
Patient Selection
- Elevated baseline 8-OHdG (>10 ng/mL in urine)
- Evidence of DNA repair impairment
- Diagnosis of AD, PD, HD, or ALS
- Age 50-80 years
Therapeutic Candidates
PARP Inhibitors
- Olaparib - FDA-approved for cancer
- Niraparib - CNS penetration
- Rucaparib - Small molecule
DNA Repair Enhancers
- Nicotinamide riboside - NAD+ precursor
- Resveratrol - SIRT1 activator
- PQQ - Mitochondrial biogenesis
Antioxidants
- Edaravone - Free radical scavenger
- CoQ10 - Mitochondrial protection
- Methylene blue - Oxidative stress reducer
Clinical Trial Design
Biomarker Enrichment
Adaptive Trial Design
- Interim DNA damage biomarker analysis at 3 months
- Dose adjustment based on biomarker response
- Biomarker-guided patient stratification
Endpoints
- Primary: Change in urinary 8-OHdG at 12 months
- Secondary: Cognitive/motor scores, brain atrophy
Cross-Links
Related Biomarkers
- [DNA Damage Response in Alzheimer's Disease](/mechanisms/dna-damage-response-alzheimers)
- [Oxidative Stress Biomarkers](/biomarkers/oxidative-stress-biomarkers-overview)
- [NAD+ Metabolism in Neurodegeneration](/mechanisms/nad-metabolism-neurodegeneration)
Related Mechanisms
- [DNA Damage Repair in Neurodegeneration](/mechanisms/dna-damage-repair-neurodegeneration)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
Clinical Trials
- [DNA Damage Repair Therapy for Neurodegeneration](/therapeutics/dna-damage-repair-therapy)
- [Clinical Trials in Alzheimer's Disease](/clinical-trials/alzheimers-disease)
Monitoring Schedule
| Timepoint | Urine 8-OHdG | CSF 8-OHdG | PAR Levels | Clinical |
|-----------|--------------|------------|------------|----------|
| Baseline | Required | Optional | Required | Required |
| 3 months | Required | - | Optional | Required |
| 6 months | Required | Required | Required | Required |
| 12 months | Required | Required | Required | Required |
Challenges
Combination Approaches
- PARP + NAD+ precursor - Synergistic DNA repair
- Antioxidant + PARP inhibitor - Reduce oxidative damage + enhance repair
- Mitochondrial + nuclear DNA - Target both compartments
Future Directions
- Blood-based DNA damage markers
- Gene therapy for DNA repair enzymes
- Personalized DNA damage profiles
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[@moreira2010]: [Moreira et al., DNA damage in Alzheimer's disease (2010)](https://doi.org/10.1016/j.jad.2009.08.031)
[@jha2015]: [Jha et al., PARP inhibitors in neurodegeneration (2015)](https://doi.org/10.1016/j.tips.2015.08.003)
[@sliwinska2020]: [Sliwinska et al., DNA repair in Parkinson's disease (2020)](https://doi.org/10.1016/j.neuropharm.2020.108019)
[@kennedy2020]: [Kennedy et al., NAD+ metabolism in aging and disease (2020)](https://doi.org/10.1038/s41580-020-00293-y)
Pathway Diagram
The following diagram shows key molecular relationships for DNA Damage Repair Therapy - Biomarker Guided based on knowledge graph edges:
Pathway Diagram
The following diagram shows the key molecular relationships involving DNA Damage Repair Therapy - Biomarker Guided discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | ideas-dna-damage-repair-therapy |
| kg_node_id | None |
| entity_type | idea |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-9d909efcf88a |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'ideas-dna-damage-repair-therapy'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-ideas-dna-damage-repair-therapy?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[DNA Damage Repair Therapy - Biomarker Guided](http://scidex.ai/artifact/wiki-ideas-dna-damage-repair-therapy)
http://scidex.ai/artifact/wiki-ideas-dna-damage-repair-therapy